Loading clinical trials...
Loading clinical trials...
An Evaluation of Treatment With Omalizumab to Improve the Asthmatic Response to an Experimental Infection With Rhinovirus
Conditions
Interventions
omalizumab
Rhinovirus (strain 16)
Locations
1
United States
University of Virginia
Charlottesville, Virginia, United States
Start Date
February 1, 2013
Primary Completion Date
May 4, 2017
Completion Date
May 4, 2017
Last Updated
July 9, 2018
NCT02327897
NCT07486401
NCT07219173
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
University of Virginia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions